cyproterone acetate has been researched along with Lymph Node Metastasis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernier, J; Billiet, I; Bolla, M; Collette, L; Cutajar, CL; Dubois, JB; Kuten, A; Mirimanoff, RO; Pfeffer, R; Sternberg, C; Storme, G; Torecilla, JL; Van der Kwast, T; Van Tienhoven, G; Warde, P | 1 |
| D'Amico, AV | 1 |
| Collette, L; Debois, M; Fosså, SD; Hoekstra, W; Karthaus, PP; Kurth, KH; Schröder, FH | 1 |
| Arriola, E; Dowsett, M; Hui, E; Smith, IE | 1 |
| Alivizatos, G; Constantinides, C; Dimopoulos, C; Mitropoulos, D | 1 |
| Debruyne, FM | 1 |
3 trial(s) available for cyproterone acetate and Lymph Node Metastasis
| Article | Year |
|---|---|
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.
Topics: Adenocarcinoma; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Canada; Cardiovascular Diseases; Chemotherapy, Adjuvant; Cyproterone Acetate; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Europe; Fractures, Bone; Goserelin; Humans; Israel; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Neoplasm Invasiveness; Neoplasm Staging; Prostatic Neoplasms; Risk Assessment; Russia; Time Factors; Treatment Outcome | 2010 |
Early versus delayed endocrine treatment of pN1-3 M0 prostate cancer without local treatment of the primary tumor: results of European Organisation for the Research and Treatment of Cancer 30846--a phase III study.
Topics: Adult; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Follow-Up Studies; Goserelin; Humans; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neoplasms; Survival Rate; Time Factors | 2004 |
Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancer.
Topics: Aged; Buserelin; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Netherlands; Orchiectomy; Prostatic Neoplasms; Remission Induction; Time Factors | 1988 |
3 other study(ies) available for cyproterone acetate and Lymph Node Metastasis
| Article | Year |
|---|---|
Is long-term androgen suppression right for everyone with locally advanced prostate cancer?
Topics: Adenocarcinoma; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Chemotherapy, Adjuvant; Cyproterone Acetate; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Fractures, Bone; Goserelin; Humans; Lymphatic Metastasis; Male; Neoplasm Invasiveness; Neoplasm Staging; Patient Selection; Prostatic Neoplasms; Risk Assessment; Time Factors; Treatment Outcome | 2010 |
Aromatase inhibitors and male breast cancer.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyproterone Acetate; Estradiol; Estrogens; Estrogens, Conjugated (USP); Humans; Letrozole; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Phobic Disorders; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Spinal Neoplasms; Testosterone; Treatment Outcome; Triazoles | 2007 |
Regression of lymphadenopathy in patient with prostatic carcinoma after hormonal manipulation.
Topics: Aged; Cyproterone Acetate; Drug Therapy, Combination; Gonadotropin-Releasing Hormone; Humans; Lymphatic Metastasis; Male; Prostatic Neoplasms; Retroperitoneal Space | 1992 |